SC 13D/A | 2024-03-25 | BAKER BROS. ADVISORS LP | MADRIGAL PHARMACEUTICALS, INC. | 2,070,544 | 10.0% | EDGAR |
SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | MADRIGAL PHARMACEUTICALS, INC. | 2,288,888 | 9.9% | EDGAR |
SC 13G/A | 2024-02-14 | PAULSON & CO. INC. | MADRIGAL PHARMACEUTICALS, INC. | 1,105,741 | 5.6% | EDGAR |
SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | MADRIGAL PHARMACEUTICALS, INC. | 50,000 | 0.2% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | MADRIGAL PHARMACEUTICALS, INC. | 1,574,742 | 8.0% | EDGAR |
SC 13G/A | 2024-02-13 | JANUS HENDERSON GROUP PLC | MADRIGAL PHARMACEUTICALS, INC. | 2,902,050 | 14.7% | EDGAR |
SC 13G/A | 2024-01-29 | BlackRock Inc. | MADRIGAL PHARMACEUTICALS, INC. | 1,212,562 | 6.1% | EDGAR |
SC 13G/A | 2024-01-22 | STATE STREET CORP | MADRIGAL PHARMACEUTICALS, INC. | - | 3.6% | EDGAR |
SC 13D/A | 2023-12-13 | BAY CITY CAPITAL LLC | MADRIGAL PHARMACEUTICALS, INC. | 567,644 | 2.9% | EDGAR |
SC 13D/A | 2023-11-21 | BAKER BROS. ADVISORS LP | MADRIGAL PHARMACEUTICALS, INC. | 1,987,702 | 10.0% | EDGAR |
SC 13G | 2023-11-13 | PAULSON & CO. INC. | MADRIGAL PHARMACEUTICALS, INC. | 1,000,000 | 5.1% | EDGAR |
SC 13G/A | 2023-10-10 | JANUS HENDERSON GROUP PLC | MADRIGAL PHARMACEUTICALS, INC. | 3,042,661 | 15.4% | EDGAR |
SC 13D/A | 2023-10-05 | BAKER BROS. ADVISORS LP | MADRIGAL PHARMACEUTICALS, INC. | 2,015,760 | 10.0% | EDGAR |
SC 13G | 2023-09-08 | JANUS HENDERSON GROUP PLC | MADRIGAL PHARMACEUTICALS, INC. | 1,910,301 | 10.3% | EDGAR |
SC 13D/A | 2023-08-08 | BAKER BROS. ADVISORS LP | MADRIGAL PHARMACEUTICALS, INC. | 1,545,113 | 8.4% | EDGAR |
SC 13D | 2023-06-20 | BAKER BROS. ADVISORS LP | MADRIGAL PHARMACEUTICALS, INC. | 1,545,113 | 8.4% | EDGAR |
SC 13G/A | 2023-02-14 | Avoro Capital Advisors LLC | MADRIGAL PHARMACEUTICALS, INC. | 1,660,000 | 9.7% | EDGAR |
SC 13G/A | 2023-02-14 | BAKER BROS. ADVISORS LP | MADRIGAL PHARMACEUTICALS, INC. | 1,545,113 | 9.0% | EDGAR |
SC 13G/A | 2023-02-14 | Deep Track Capital, LP | MADRIGAL PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-14 | ARMISTICE CAPITAL, LLC | MADRIGAL PHARMACEUTICALS, INC. | 208,000 | 1.2% | EDGAR |